Want to track NYKD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nykode Therapeutics ASA (NYKD) Statistics
Valuation metrics
Market Cap 351.77M
Enterprise value 59.3M
Trailing P/E (ttm) -7.26
Forward P/E -
PEG ratio -0.11
Price/Sales (ttm) 546.26
Price/Book (mrq) 1.24
Enterprise Value/Revenue 299.49
Enterprise Value/EBITDA -3.16
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 435.54K
Average volume (90 days) 948.05K
Price summary
52-Week low 1.44
52-Week high 4.1
Beta -
50-Day moving average 3.18
200-Day moving average 2.97
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -75.26%
Operating margin -140.22%
Operational effectiveness
Return on assets -0.16%
Return on equity -0.16%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.05
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.16
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 12.66%
Book value per share (mrq) 0.27
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
